INDV — Indivior Pharmaceuticals Inc stock price, charts and financials

QT69Indivior Pharmaceuticals Inc

Indivior Pharmaceuticals Inc (NASDAQ: INDV) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
34.88
-0.81-2.27%
OverviewShort InterestFilings
INDVQT69Indivior Pharmaceuticals Inc·NASDAQ
34.88-2.27%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 17, 2026425Prospectus / business-combination communication
Sep 17, 20268-KCurrent report
Sep 15, 20268-KCurrent report
Sep 11, 2026EFFECTNotice of effectiveness
Sep 11, 2026424B3Prospectus
Sep 09, 2026S-4/AS-4/A
Aug 28, 2026S-4Registration statement (M&A)
Aug 27, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 05, 20264Statement of changes in beneficial ownership
Aug 04, 2026425Prospectus / business-combination communication
Aug 03, 2026425Prospectus / business-combination communication
Aug 03, 20268-KCurrent report
Aug 03, 2026425Prospectus / business-combination communication
Aug 03, 20268-KCurrent report
Aug 03, 202610-QQuarterly report
Aug 03, 2026425Prospectus / business-combination communication
Aug 03, 20268-KCurrent report
Aug 03, 2026425Prospectus / business-combination communication
Jul 13, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 20268-KCurrent report
#1 / 25 of 521
Page
▼
/ 21